Improved pharmacological properties for superoxide dismutase modified with beta-cyclodextrin-carboxymethylcellulose...

Area of Science:

• Biochemistry
• Materials Science
• Pharmacology

Background:

• Superoxide dismutase (SOD) is a crucial antioxidant enzyme.
• Its therapeutic application is limited by short plasma half-life and suboptimal anti-inflammatory activity.

Purpose of the Study:

• To enhance the anti-inflammatory activity and pharmacokinetic profile of superoxide dismutase.
• To investigate the efficacy of glycosidation using cyclodextrin-branched carboxymethylcellulose.

Main Methods:

• Glycosidation of superoxide dismutase with cyclodextrin-branched carboxymethylcellulose.
• Quantification of polymer conjugation.
• Assay of residual enzyme activity.
• Evaluation of anti-inflammatory activity in vitro.
• Determination of plasma half-life in vivo.

Main Results:

• The modified enzyme achieved a conjugation level of 1.4 mol polymer per mol protein.
• The glycosidated superoxide dismutase retained 87% of its initial enzymatic activity.
• Anti-inflammatory activity was increased 2.2-fold.
• Plasma half-life was extended from 4.8 minutes to 7.2 hours.

Conclusions:

• Glycosidation with cyclodextrin-branched carboxymethylcellulose is an effective strategy to improve superoxide dismutase's therapeutic potential.
• The modification significantly enhances anti-inflammatory efficacy and prolongs enzyme circulation time.
• This approach offers a promising avenue for developing improved antioxidant and anti-inflammatory therapies.